Avita Medical Inc.
RCEL | NASDAQ
$11.66
+$0.82 (+7.56%)
Sep 22, 2026, 11:54 AM ET · Market open
Market Data
Market Cap $269.3M
Enterprise Value $259.98M
Beta 2.02
Average Volume 400.59K
Shares Outstanding (Diluted) 30.75M
Shares Change YoY 16.62%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US05380C1027
Price Performance
Price Change 1M 7.4%
Price Change 3M 176.5%
Price Change 6M 171.7%
Price Change YTD 212.4%
Price Change 1Y 83.1%
Price Change 3Y -22.4%
Price Change 5Y -40.5%
1M CAGR (ann.) 39.5%
1Y CAGR (ann.) 95.7%
5Y CAGR (ann.) -10.5%
All-Time CAGR -5.7%
Valuation
PE Ratio -0.30
Forward PE 28.83
PEG Ratio -0.23
Forward PEG 0.13
PS Ratio 3.56
Forward PS 2.40
PB Ratio -9.67
P/FCF Ratio -7.99
P/Adj. FCF Ratio -6.41
P/OCF Ratio -13.72
EV/Sales 3.44
EV/EBIT -6.90
EV/EBITDA -7.27
EV/FCF -7.72
Earnings Yield -330.5%
FCF Yield -12.5%
Adj. FCF Yield -15.6%
Financial Health
Net Cash $9.31M
Total Debt $1.82M
Cash & Short-Term Investments $11.14M
Total Assets $47.78M
Current Ratio 0.41
Quick Ratio 0.34
Debt / Equity Ratio -1.74
Debt / EBITDA -0.05
Debt / FCF -0.05
OCF / Debt -18.82
Interest Coverage -6.52
Altman Z-Score -12.40
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 81.6%
Operating Profit Margin -46.6%
EBITDA Margin -45.5%
Net Profit Margin -57.0%
FCF Margin -44.5%
Adj. FCF Margin -55.6%
SBC / Revenue 9.6%
SBC Impact (per share) -24.8%
Returns
Return on Assets -90.2%
Return on Equity 231.9%
Return on Invested Capital -136.9%
Return on Capital Employed 168.2%
Return on Tangible Assets -101.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 22.8%
Revenue CAGR 5Y 20.9%
Revenue CAGR 10Y 54.1%
EPS CAGR 3Y -127.8%
EPS CAGR 5Y -83.0%
EPS CAGR 10Y -35.5%
FCF CAGR 3Y 27.5%
FCF CAGR 5Y -13.1%
FCF CAGR 10Y -13.4%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 8
EPS Growth Next 3Y 35.9%
Revenue Growth Next 3Y 75.9%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.24
EPS Growth Est (next Q) -47.9%
Revenue Est (next Q) $22.35M
Revenue Growth Est (next Q) 31.0%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $11
Price Target Upside 1.5%
Cash Flow
Operating Cash Flow $-34.3M
Free Cash Flow $-33.69M
Adj. Free Cash Flow $-42.03M
FCF Per Share -$0.77
OCF Per Share -$0.79
OCF/S Ratio -32.0%
Income Statement
Revenue $75.63M
Gross Profit $61.68M
Operating Income $-35.22M
EBITDA $-35.78M
Net Income $-43.08M
EPS (Diluted) -$35.83
Revenue / Employee $334.65K
Profit / Employee $-190.63K
Employees 226
Add to Watchlist
Select watchlists to add or remove RCEL